• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine: Precision in S

  2026-07-16

  1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine (PP 3) redefines assay specificity in Src kinase signaling pathway research by serving as the negative control for PP 2. Backed by high purity and optimal solubility, PP 3 enables rigorous validation of kinase inhibitor studies and streamlines troubleshooting for complex cellular signaling workflows.

• Advancing Sumoylation Studies with 2-D08 (2’,3’,4’-trihydrox

  2026-07-15

  This article addresses common experimental challenges in posttranslational modification and cell viability assays, emphasizing how 2-D08 (2’,3’,4’-trihydroxyflavone) (SKU C4445) offers reproducible, selective, and workflow-compatible solutions. Scenario-driven Q&A blocks provide actionable guidance and highlight the scientific rigor behind APExBIO’s offering.

• Imatinib Hydrochloride: Advanced Protocols for Kinase Inhibi

  2026-07-15

  Imatinib hydrochloride (STI571 hydrochloride) is a gold-standard tyrosine kinase inhibitor for dissecting oncogenic signaling in CML and GIST research. This guide integrates new insights on dual-action kinase inhibition, protocol optimization, and troubleshooting, enabling reproducible, high-specificity results for cancer-focused laboratories.

• Cholecystokinin Octapeptide Ammonium: Advanced Research Appl

  2026-07-14

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) enables highly specific modeling of neurobehavioral, apoptotic, and cardiometabolic processes. This guide translates bench research into actionable protocols, troubleshooting strategies, and comparative advantages that boost reproducibility and experimental insight.

• NLRP10 Drives Keratinocyte Survival and Differentiation in A

  2026-07-14

  This study elucidates the essential role of NLRP10 in maintaining epidermal homeostasis, highlighting its function in promoting keratinocyte survival and P63-dependent differentiation. By demonstrating that NLRP10 downregulation contributes to impaired skin barrier function in atopic dermatitis, the research provides a mechanistic basis for targeting NLRP10 in future therapeutic strategies.

• Tolazoline as an α2-Adrenergic Receptor Antagonist: Applied

  2026-07-13

  Tolazoline’s unique pharmacology enables precise manipulation of α2-adrenergic receptor signaling in both islet function and airway smooth muscle assays. This guide details experimental workflows, practical troubleshooting, and actionable insights anchored by recent equine airway research and comparative protocol analysis.

• N-MYC/eIF4G1 Axis Drives Survival in inv(16) AML via CBFβ-SM

  2026-07-13

  This study identifies N-MYC as a critical regulator of cell survival in inv(16) acute myeloid leukemia (AML), acting through the translational factor eIF4G1. The work demonstrates that targeting the CBFβ-SMMHC fusion protein downregulates MYCN and disrupts leukemia maintenance, providing both mechanistic insight and a rationale for targeted research strategies.

• Necrosulfonamide: Advanced MLKL Inhibition for Necroptosis A

  2026-07-12

  Necrosulfonamide (NSA) offers precision inhibition of MLKL-mediated necroptosis, enabling robust and reproducible cell death pathway research. This article provides actionable workflows, troubleshooting strategies, and translational insights grounded in recent cardiovascular research and advanced disease modeling.

• HyperScribe All in One mRNA Synthesis Kit Plus 1 in Advanced

  2026-07-10

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-evasive mRNA synthesis, enabling robust RNA vaccine and functional RNA research. Its integrated modifications and polyadenylation steps support high-yield, translationally potent mRNA production, as illustrated by recent breakthroughs in mRNA vaccine development against Chlamydia psittaci.

• 25-Hydroxycholesterol Reprograms TAMs via AMPK–STAT6 Pathway

  2026-07-09

  Xiao et al. reveal that 25-hydroxycholesterol (25HC) in tumor-associated macrophages drives immunosuppression by activating lysosomal AMPKα and STAT6-dependent metabolic reprogramming. Targeting CH25H, the enzyme generating 25HC, enhances anti-tumor T cell responses and synergizes with checkpoint blockade, offering a new immunometabolic checkpoint for cancer therapy.

• Annexin V as a Phosphatidylserine Binding Protein: Applied W

  2026-07-09

  Annexin V, human recombinant, stands out as a high-affinity phosphatidylserine binding protein for sensitive and reproducible apoptosis assays. This article unpacks robust experimental workflows, advanced troubleshooting, and translational use-cases, empowering researchers in cancer and cell death research to maximize the value of APExBIO’s trusted reagent.

• KR-12 (human) TFA: Reliable Antimicrobial Peptide for Reprod

  2026-07-08

  This article addresses core challenges in cell viability, proliferation, and cytotoxicity workflows where antimicrobial interference, sensitivity, and reproducibility are critical. Using scenario-driven Q&A, it demonstrates how 'KR-12 (human) TFA' (SKU C8754) delivers validated, data-backed solutions for bench scientists. Evidence from peer-reviewed studies and the APExBIO product dossier supports practical recommendations.

• WAY-100635 in Behavioral Pharmacology of 5-HT1A Receptors

  2026-07-08

  WAY-100635 stands out as a gold-standard tool for dissecting the role of 5-HT1A receptors in neuroscience and behavioral pharmacology. Its selectivity and in vivo efficacy enable precise modulation of serotonergic pathways, as validated in translational pain and affective studies. This article bridges cutting-edge reference findings with best-practice workflows, troubleshooting, and practical assay design.

• Annexin V-APC/7-AAD Apoptosis Kit: Optimizing Apoptosis Dete

  2026-07-07

  The Annexin V-APC/7-AAD Apoptosis Kit empowers researchers to swiftly distinguish between apoptotic and necrotic cells, streamlining both high-throughput screening and mechanistic studies. Its robust, one-step workflow and dual-parameter resolution set a new standard for apoptosis and necrosis detection in cancer and immunology research.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Applied Workfl

  2026-07-07

  The HyperScribe SP6 High Yield RNA Synthesis Kit empowers researchers to generate, label, and modify RNA with unmatched yield and flexibility. This article dissects practical protocols, advanced applications, and troubleshooting tactics, drawing on recent discoveries in viral immunity and peer-reviewed best practices for RNA synthesis.

448 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page